168 related articles for article (PubMed ID: 36480200)
1. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
[TBL] [Abstract][Full Text] [Related]
2. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
3. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
Ma SJ; Yu H; Khan M; Yu B; Santhosh S; Chatterjee U; Gill J; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
Oral Oncol; 2022 Oct; 133():106054. PubMed ID: 35933937
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
[TBL] [Abstract][Full Text] [Related]
5. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
Lassen P; Huang SH; Su J; Waldron J; Andersen M; Primdahl H; Johansen J; Kristensen CA; Andersen E; Eriksen JG; Hansen CR; Alsner J; Lilja-Fisher J; Bratman SV; Ringash J; Kim J; Hope A; Spreafico A; de Almeida J; Xu W; O'Sullivan B; Overgaard J
Int J Cancer; 2022 Apr; 150(8):1329-1340. PubMed ID: 34792199
[TBL] [Abstract][Full Text] [Related]
7. Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
Broughman JR; Xiong DD; Moeller BJ; Contrera KJ; Prendes BL; Lamarre ED; Ku JA; Burkey BB; Woody NM; Joshi NP; Adelstein DJ; Geiger JL; Frenkel CH; Milas ZL; Brickman DS; Sumrall AL; Carrizosa DR; Greskovich JF; Koyfman SA; Ward MC
Cancer; 2020 Jun; 126(12):2784-2790. PubMed ID: 32167593
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
9. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes.
Chen SY; Last A; Ettyreddy A; Kallogjeri D; Wahle B; Chidambaram S; Mazul A; Thorstad W; Jackson RS; Zevallos JP; Pipkorn P
Am J Otolaryngol; 2021; 42(3):102915. PubMed ID: 33482566
[TBL] [Abstract][Full Text] [Related]
10. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
[TBL] [Abstract][Full Text] [Related]
13. Impact of active smoking on outcomes in HPV+ oropharyngeal cancer.
Xiao R; Pham Y; Ward MC; Houston N; Reddy CA; Joshi NP; Greskovich JF; Woody NM; Chute DJ; Lamarre ED; Prendes BL; Lorenz RR; Scharpf J; Burkey BB; Geiger JL; Adelstein DJ; Koyfman SA
Head Neck; 2020 Feb; 42(2):269-280. PubMed ID: 31769100
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
Guo TW; Saiyed F; Yao CMKL; Kiong KL; Martinez J; Sacks R; Lee JJ; Moreno AC; Frank SJ; Rosenthal DI; Glisson BS; Ferrarotto R; Mott FE; Johnson FM; Myers JN
Cancer; 2021 Aug; 127(16):2916-2925. PubMed ID: 33873251
[TBL] [Abstract][Full Text] [Related]
15. RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
Fakhry C; Tewari SR; Zhang L; Windon MJ; Bigelow EO; Drake VE; Rooper LM; Troy T; Ha P; Miles BA; Mydlarz WK; Eisele DW; D'Souza G
Cancer; 2021 Oct; 127(19):3523-3530. PubMed ID: 34143891
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
Fakhry C; Zhang Q; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Jones CU; Yom SS; Wong SJ; Ridge JA; Rao SSD; Bonner JA; Vigneault E; Raben D; Kudrimoti MR; Harris J; Le QT; Gillison ML
J Clin Oncol; 2017 Dec; 35(36):4057-4065. PubMed ID: 28777690
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD
Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479
[TBL] [Abstract][Full Text] [Related]
18. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
Burningham K; Moore W; Moon D; Avkshtol V; Day AT; Sumer B; Vo D; Bishop JA; Hughes R; Sher DJ
Oral Oncol; 2021 Dec; 123():105623. PubMed ID: 34801975
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
